Ki-1+ Anaplastic Large Cell Lymphoma

Known as: Lymphoma, Ki-1, CD30+ Anaplastic Large Cell Lymphoma, Anaplastic large-cell lymphoma 
A peripheral (mature) T-cell lymphoma, consisting of usually large anaplastic, CD30 positive cells. The majority of cases are positive for the… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1937-2018
010020019372017

Related topics

Related topics

27 relations
AnaplasiaAntigens, CD30Atypical lymphocyteHematopoietic and Lymphoid Cell
(More)

Narrower (1)

Systemic Anaplastic Large Cell Lymphoma

Related mentions per year

Related mentions per year

1936-2019
19401960198020002020
Ki-1+ Anaplastic Large Cell Lymphoma
cancer cell
Lymphoma
Neoplastic Cell
Microbiological
prevention & control

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
ALK: a tyrosine kinase target for cancer therapy
The anaplastic lymphoma kinase (ALK) gene plays an important physiologic role in the development of the brain and can be… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2016
Review
2016
The Emerging Role of Tetraspanins in the Proteolytic Processing of the Amyloid Precursor Protein
Tetraspanins are a family of ubiquitously expressed and conserved proteins, which are characterized by four transmembrane domains… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2012
Highly Cited
2012
The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
Progress has been made recently in developing antibody-drug conjugates (ADCs) that can selectively deliver cancer drugs to tumor… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas.
BACKGROUND Hodgkin's lymphoma and anaplastic large-cell lymphoma are the two most common tumors expressing CD30. Previous… (More)
  • table 1
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
1999
Highly Cited
1999
A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation.
Anaplastic large cell lymphomas (ALCL) are frequently associated with the t(2;5)(p23;q35). This translocation fuses the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies.
PURPOSE To prove prospectively the efficacy of a short-pulse chemotherapy for treatment of Ki-1 anaplastic large-cell lymphoma… (More)
Is this relevant?
1994
1994
Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entity.
The morphology of anaplastic large-cell lymphoma (ALCL) is associated with a clinical syndrome of peripheral lymphadenopathy… (More)
Is this relevant?
Highly Cited
1990
Highly Cited
1990
CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35.
A chromosomal translocation involving a breakpoint on the long arm of chromosome 5 at position q35 has been reported previously… (More)
Is this relevant?
1990
1990
Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1 + with a high content of reactive histiocytes).
We describe 13 cases of a peculiar lymphoid tumour containing very large numbers of reactive histiocytes. The tumours occurred in… (More)
Is this relevant?
Highly Cited
1989
Highly Cited
1989
Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization.
Forty-two cases of Hodgkin's disease (HD) and 22 cases of Ki-1-positive anaplastic large cell (Ki-1 + ALC) lymphoma were examined… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?